Application Value of Novel Inflammatory Indicators in Response to Ursodeoxycholic Acid Therapy in Patients with Primary Biliary Cholangitis
Siqi Liu,1 Yongli Pang,2 Xiaoxi Wang,3 Ruihang Lin,4 Siqing Tunala5 1Inner Mongolia Medical University, Hohhot, Inner Mongoli, People’s Republic of China; 2Ordos second People’s Hospital, Ordos, Inner Mongoli, People’s Republic of China; 3People’s Hospital of Ordos Dongsheng District, Ordos, Inner M...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-02-01
|
| Series: | International Journal of General Medicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/application-value-of-novel-inflammatory-indicators-in-response-to-urso-peer-reviewed-fulltext-article-IJGM |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850025352822259712 |
|---|---|
| author | Liu S Pang Y Wang X Lin R Tunala S |
| author_facet | Liu S Pang Y Wang X Lin R Tunala S |
| author_sort | Liu S |
| collection | DOAJ |
| description | Siqi Liu,1 Yongli Pang,2 Xiaoxi Wang,3 Ruihang Lin,4 Siqing Tunala5 1Inner Mongolia Medical University, Hohhot, Inner Mongoli, People’s Republic of China; 2Ordos second People’s Hospital, Ordos, Inner Mongoli, People’s Republic of China; 3People’s Hospital of Ordos Dongsheng District, Ordos, Inner Mongoli, People’s Republic of China; 4Ordos Central Hospital, Ordos, Inner Mongoli, People’s Republic of China; 5Ordos Mongolian Medicine Hospital, Ordos, Inner Mongoli, People’s Republic of ChinaCorrespondence: Siqing Tunala, Ordos Mongolian Medicine Hospital, Ordos, Inner Mongoli, People’s Republic of China, Email tutu88600@126.comObjective: To analyze the application value of novel inflammation indicators such as the lymphocyte/monocyte ratio (LMR), neutrophil/lymphocyte ratio (NLR), and platelet/lymphocyte ratio (PLR) in patients with primary biliary cholangitis (PBC) undergoing ursodeoxycholic acid (UDCA) treatment. We plan to further seek simple and convenient methods to assess the response of patients to UDCA treatment.Methods: We recorded routine blood tests, liver function, and vitamin D (VD) levels of PBC patients and healthy controls visiting the hospital between October 2022 and October 2023. LMR, NLR, and PLR were calculated, and differences between the two groups were analyzed. PBC patients were divided into good response and poor response groups according to the Paris I criteria, and differences in laboratory tests between the two groups were analyzed. The predictive value of novel inflammation indicators in UDCA treatment response was further analyzed using ROC analysis.Results: LMR and VD levels were significantly lower in the PBC group compared to the control group (P=0.000, P=0.000). In PBC patients, the good response group had higher LMR than the poor response group (P=0.001) and lower NLR than the poor response group (P=0.015). The areas under the ROC curve for LMR and NLR were 0.682± 0.049 and 0.630± 0.052, respectively. There was a significant negative correlation between PLR and VD in PBC patients (r=− 0.252, P=0.005).Conclusion: Low LMR and high NLR may indicate poor treatment response. And PLR also have certain predictive values for treatment response.Keywords: primary biliary cholangitis, lymphocyte/monocyte ratio, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, vitamin D |
| format | Article |
| id | doaj-art-2ebff2f086354da99fe061d912ce0523 |
| institution | DOAJ |
| issn | 1178-7074 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of General Medicine |
| spelling | doaj-art-2ebff2f086354da99fe061d912ce05232025-08-20T03:00:51ZengDove Medical PressInternational Journal of General Medicine1178-70742025-02-01Volume 18897905100368Application Value of Novel Inflammatory Indicators in Response to Ursodeoxycholic Acid Therapy in Patients with Primary Biliary CholangitisLiu SPang YWang XLin RTunala SSiqi Liu,1 Yongli Pang,2 Xiaoxi Wang,3 Ruihang Lin,4 Siqing Tunala5 1Inner Mongolia Medical University, Hohhot, Inner Mongoli, People’s Republic of China; 2Ordos second People’s Hospital, Ordos, Inner Mongoli, People’s Republic of China; 3People’s Hospital of Ordos Dongsheng District, Ordos, Inner Mongoli, People’s Republic of China; 4Ordos Central Hospital, Ordos, Inner Mongoli, People’s Republic of China; 5Ordos Mongolian Medicine Hospital, Ordos, Inner Mongoli, People’s Republic of ChinaCorrespondence: Siqing Tunala, Ordos Mongolian Medicine Hospital, Ordos, Inner Mongoli, People’s Republic of China, Email tutu88600@126.comObjective: To analyze the application value of novel inflammation indicators such as the lymphocyte/monocyte ratio (LMR), neutrophil/lymphocyte ratio (NLR), and platelet/lymphocyte ratio (PLR) in patients with primary biliary cholangitis (PBC) undergoing ursodeoxycholic acid (UDCA) treatment. We plan to further seek simple and convenient methods to assess the response of patients to UDCA treatment.Methods: We recorded routine blood tests, liver function, and vitamin D (VD) levels of PBC patients and healthy controls visiting the hospital between October 2022 and October 2023. LMR, NLR, and PLR were calculated, and differences between the two groups were analyzed. PBC patients were divided into good response and poor response groups according to the Paris I criteria, and differences in laboratory tests between the two groups were analyzed. The predictive value of novel inflammation indicators in UDCA treatment response was further analyzed using ROC analysis.Results: LMR and VD levels were significantly lower in the PBC group compared to the control group (P=0.000, P=0.000). In PBC patients, the good response group had higher LMR than the poor response group (P=0.001) and lower NLR than the poor response group (P=0.015). The areas under the ROC curve for LMR and NLR were 0.682± 0.049 and 0.630± 0.052, respectively. There was a significant negative correlation between PLR and VD in PBC patients (r=− 0.252, P=0.005).Conclusion: Low LMR and high NLR may indicate poor treatment response. And PLR also have certain predictive values for treatment response.Keywords: primary biliary cholangitis, lymphocyte/monocyte ratio, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, vitamin Dhttps://www.dovepress.com/application-value-of-novel-inflammatory-indicators-in-response-to-urso-peer-reviewed-fulltext-article-IJGMprimary biliary cholangitislymphocyte/monocyte rationeutrophil/lymphocyte ratioplatelet/lymphocyte ratiovitamin d |
| spellingShingle | Liu S Pang Y Wang X Lin R Tunala S Application Value of Novel Inflammatory Indicators in Response to Ursodeoxycholic Acid Therapy in Patients with Primary Biliary Cholangitis International Journal of General Medicine primary biliary cholangitis lymphocyte/monocyte ratio neutrophil/lymphocyte ratio platelet/lymphocyte ratio vitamin d |
| title | Application Value of Novel Inflammatory Indicators in Response to Ursodeoxycholic Acid Therapy in Patients with Primary Biliary Cholangitis |
| title_full | Application Value of Novel Inflammatory Indicators in Response to Ursodeoxycholic Acid Therapy in Patients with Primary Biliary Cholangitis |
| title_fullStr | Application Value of Novel Inflammatory Indicators in Response to Ursodeoxycholic Acid Therapy in Patients with Primary Biliary Cholangitis |
| title_full_unstemmed | Application Value of Novel Inflammatory Indicators in Response to Ursodeoxycholic Acid Therapy in Patients with Primary Biliary Cholangitis |
| title_short | Application Value of Novel Inflammatory Indicators in Response to Ursodeoxycholic Acid Therapy in Patients with Primary Biliary Cholangitis |
| title_sort | application value of novel inflammatory indicators in response to ursodeoxycholic acid therapy in patients with primary biliary cholangitis |
| topic | primary biliary cholangitis lymphocyte/monocyte ratio neutrophil/lymphocyte ratio platelet/lymphocyte ratio vitamin d |
| url | https://www.dovepress.com/application-value-of-novel-inflammatory-indicators-in-response-to-urso-peer-reviewed-fulltext-article-IJGM |
| work_keys_str_mv | AT lius applicationvalueofnovelinflammatoryindicatorsinresponsetoursodeoxycholicacidtherapyinpatientswithprimarybiliarycholangitis AT pangy applicationvalueofnovelinflammatoryindicatorsinresponsetoursodeoxycholicacidtherapyinpatientswithprimarybiliarycholangitis AT wangx applicationvalueofnovelinflammatoryindicatorsinresponsetoursodeoxycholicacidtherapyinpatientswithprimarybiliarycholangitis AT linr applicationvalueofnovelinflammatoryindicatorsinresponsetoursodeoxycholicacidtherapyinpatientswithprimarybiliarycholangitis AT tunalas applicationvalueofnovelinflammatoryindicatorsinresponsetoursodeoxycholicacidtherapyinpatientswithprimarybiliarycholangitis |